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I. INTRODUCTION
Unique costs are those which can be determined by asking, '"Which 
costs would not have been incurred had this product not been produced?" 
The only relevant costs for analyzing profitability of a certain product 
are those costs which can be uniquely attributed to the production and 
sale of the particular product or service.
Traditional cost accounting techniques are not useful to most 
service organizations, including regional blood services. However, 
adequate delivery of services depends on, among other things, reliable 
cost data. Attempts to apply product cost systems used in the manufac­
turing industries to service organizations have been disappointing. This 
is because traditional product cost accounting deals with valuations of 
inventories in various stages of completion, from raw materials to which 
direct labor is appilied, to finished goods for which short-term sales 
plans are prepared.
For organizations in which service, rather than goods, is the 
product, inventory costs are not relevant. The challenge, then, is two­
fold: (1) to determine which costs are relevant in measuring the profit­
ability of a particular service, and (2) to develop methods for asaigjilng 
relevant costs to the service.
Profitability analysis is helpful in identifying relevant costs 
and their assignment to specific services. Profitability of a service 
may be defined as the increase in earnings that is the result of the 
service having been offered and accepted. Thus, the only relevant costs
1
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for profitability analysis of a specific service are those that can be 
uniquely attributed to the offering of the particular service. All other 
costs are joint costs. Revenues minus uniquely attributable costs con­
stitute the total profit contribution of a particular service. The total 
profit contribution provides the relevant Information for service profit­
ability analysis.^
Admittedly, the concept of profitability becomes a bit fuzzy when 
specific services contribute to preservation of life or health of human 
beings. Values of service rendered or benefits received are not readily 
measurable in dollars, because our present knowledge does not enable us
to determine the value of health, education and the like in accounting 
2terms. For a nonprofit organization, profitability analysis can provide 
a measure of proper management of varied resources.
In this study the author proposed to accurately identify the
unique costs in a regional blood center, and to develop a system for
-
assigning unique costs to services. The type of organization under study 
differs fr<m other businesses in that it is nonprofit, and relies on 
volunteers for delivery of Its services.
Persons responsible for management of blood banks and other 
service organizations should find use for improved cost Information, 
whether for fiscal nontrol, or for explanations to parties who provide 
resources or request compliance with guidelines for wage and price
1John Dearden, "Cost Accounting Carnes to Service Industries," 
Harvard Business Review. September-October 1978, p. 14.
2Emerson 0. Henke. Accounting for Nonprofit Organizations. 2d ed., 
(Belmont, California: Wadsworth Publishing Company, Inc.), p. 173.
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3standards. Consumers are Increasingly concerned with the costs of 
living. In the special case of blood banks, a voluntary (unpaid) blood 
donor can become quite Interested In costs of services provided when and 
If, as a patient, he becomes the recipient of something donated that may 
cost in excess of $100 per unit when he becomes a recipient.
The Financial Accounting Standards Board addressed the matter of 
users and user needs for financial reports made by nonbusiness organiza­
tions In a recent research report. In Its study, the FASB's "Issue One" 
was:
Is the following list of primary users of financial 
report Information adequate for the purpose of id^tlfy- 
Ing needs for such Information: governing bodies, inves­
tors and creditors, resource providers, oversight bodies, 
and constituents?^
"Issue Two" concerned user needs;
Is the following list of the types of financial re- 
. port information needed by users adequate as a basis for 
deciding how best to meet these needs; financial viabi­
lity, fiscal compliance, management performance, and cost 
of services provided?^
The FASB stated Its first two issues In terms of broad questions 
"because of the highly subjective nature of any list of users," and 
resolution of the Issue cannot be had by selection of what appears to be 
the best altexmatlve. Although the study formally excluded Internal users, 
the authors noted that of^en managers made even more use of financial 
reports than did the users Identified In the Issue statements.
3Such as The Council on Wage and Price Stability, "Wage and Price 
Standards," Advance for Release at Noon ËST Wednesday, December 13, 1978, 
Executive Office of the President, Washington, D.C^
4Robert N. Anthony, Financial Accounting In Nonbusiness Organiza­
tions, (Stamford, Connecticut: Financial Accounting Standards Boards 1978), 
p. 47.
^Ibld., p. 52.
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11. BACKGROUND
The primary reference and basis for this study is Bearden's article 
"Cost Accounting Comes to Service Industries,"* A summary of his article, 
and related information follows.
Cost accounting techniques are most often used by manufacturing 
industries, for the purposes of Cl) inventory valuation, C2) cost con­
trol, (3) short-term planning, and (4) product profitability analysis.
For inventory valuaticm purposes, accounting conventions Call for 
"product costs" Ccosts that add inventory value to a manufactured product 
by changing the form of the product), and “period" costs (all other costs, 
since they are recorded as expenses in the period in which they are incur­
red). However, the distinction between product and period cost has little 
relevance to a service organization, because there are usually no finished 
goods inventories to be evaluated and all costs are basically period costs. 
Also, techniques for allocating administrative costs become economically 
meaningless if these costs do not change whether or not the product being 
costed is produced.
Most cost control systems utilize some system of standard costs.
A cost standard is determined for each product, based on estimates of the 
amounts of direct material, direct labor, and factory overhead that go 
Into it. Standard costs are more suited to mass production operations
*John Dearden, "Cost Accounting Comes to Service Industries," Harvard 
Business Review, Septendier-October, 1978.
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where uniform products are manufactured in large quantities. Since, in 
a service organization, direct materials and labor, the biggest targets 
for cost control efforts, tend to be minimal when compared to overhead 
costs, application of standard cost procedures is likely to give disap­
pointing results.
Another approach to classification of costs, is to divide them 
into fixed and variable. This may be done to facilitate short term 
planning decisions with regard to volume and prices of products. Fixed 
costs are those which remain unchanged for the short term, with respect 
to production volume. Variable costs change directly and proportionately 
with volume, assuming the plant has adequate capacity and plans to stay 
in business. Since service organizations tend to plan for the long term, 
rather than the short, and have relatively low variable costs as Just 
defined, calculation of variable costs is not very helpful.
Product profitability Information, on the other hand, is useful 
to service organizations for directing nianagement's attention to situations 
which involve problem diagnosis, Icmg range planning, trend analysis and 
pricing decisions. Even where a price is not charged or cannot be changed, 
profitability analysis informs management of the extent to idiich a service 
is being subsidized.
Profitability is measured in terms of profits which are calculated 
by subtracting the costs of supplying the product or service from the 
revenue that results from the transaction. The accurate identification 
of revenues with specific products is not difficult, but calculating the 
cost of services is the unique problem for service organizations.
In order to use words compatible with most literature on the sub­
ject, and for the purpose of this study, the term "product” is used to
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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mean any Identifiable service, or product such as a specific blood test.
In some cases a service and a product may be inseparable. A product group 
means a group of related products, such as plasma products. A product line 
is used to mean a number of related product groups, such as whole blood and 
its components.
Analysis of product profitability is hierarchical; it starts with 
the broadest definition of a product and moves dowiward to a unique product 
that can no longer be subdivided.
The traditional income statement will provide a reliable indication 
of a blood center's profitability. Calculating the profitability of each 
product line is done by analyzing the costs of the line and separating 
joint costs from costs that are incurred uniquely for each product line.
To determine unique costs, one asks, "Which costs would not have been 
incurred had product line "X" not been produced?" The question is asked 
of each cost center, General Operations, Collection, Recruitment, Distri­
bution, Reference and Consultation, and Preparation. Joint cost is the 
difference between the total uni^pie costs and the total cost center costs; 
joint cost is not assigned to the product line. Unique costs are assigned 
to the product line. In the case of the blood center, virtually the entire 
facility is used to produce the major product line; therefore, most costs 
are unique to the major product line.
Next, each product line is broken down into its next divisible unit, 
that is, its product groups. Each product group is analyzed by the same 
process as described for the product lines. However, at this point, some 
costs uniquely attributable to the product line, i.e., routine services 
with respect to whole blood and components, will become joint with respect 
to the product group. For instance, costs of routine tests done on whole
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
blood would be joint with respect to components. Additional costs to pro­
duce components from whole blood would be unique to the component group.
Finally, the profitability of each product is analyzed, and unique 
costs are assigned to the product on the basis of answers to the question, 
"Which costs would not have occurred if this product had not been produced, 
but all other products in the group had been produced?"
Revenue for each product is readily identifiable, but is not 
necessarily proportional to the cost of the product. See Figure 1 for 
portrayal of product lines, product groups, and products.
Routine Services + Special Services * 2 Product Lines
Cell Pr<>ducts + Plasma ]'roducts • 2 Product Groups 
•
Whole . R e d  Blood Frozen Deglycerinized . Products Blood + Cells + Cells /  Cells 4 Products
Fig. 1. Example of Product Lines, Product Groups and Products.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
111. RESEARCH AND DEVELOPMENT OF A UNICPS COST SYSTEM
A "Unique Costs Worksheet" and instructions for its use were 
developed. A separate worksheet was prepared for each product. Instruc­
tions and completed worksheets form Appendices A and B.
After the product worksheets were completed, information on them 
was summarized for product lines, product groups and products for one 
regional blood center. Unique costs were determined for each category, 
as estimated for the fiscal year ending June 30, 1981, Expected revenues 
for the same period were compared to unique costs, in order to measure - 
the total profit contribution of each product, product group and product 
line. (Appendix E).
Information for this report was gathered from the detailed budget 
package of a regional blood center, from departmental cost reports, from 
observation and interviews in person and by telephone, from a mail survey 
regarding charges for specialized services, from the American Red Cross's 
"Blood Program Fiscal Manual," from year-end audited fiscal reports for 
the year ending June 30, 1979, from paid staff as well as volunteers and 
product users, and from individual invoices.
In a highly technical service such as a modem blood bank, timely 
investments in human assets are essential, and some are actually required 
by regulatory agencies such as the Federal Bureau of Biologies which 
licenses blood banks as drug manufacturing entities. From a managerial 
point of veiw it makes sense to regard training costs of paid and volunteer
8
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staff as assets which can be depreciated similarly to capital assets, 
because the passage of time tends to bring about deterioration or obsoles­
cence, or both.
As with the purchase of a new piece of capital equipment, the 
purchase of training and other start-up essentials associated with a new 
technical procedure can involve large expenditures of funds which are 
more reasonably allocated to the useful life span of the training than 
written off as current expenses. In this study, unique costs of training 
were handled the same way as unique costs of specific capital equipment, 
i.e., like depreciation expenses spread over several years.
In this unique service/manufacturing organization, all raw material 
is donated, and much labor is also donated, so many costs of production 
are simply not recorded in financial reports of any kind. Benefits to the 
donors are measured more in terms of personal satisfaction than monetary 
revenue.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
IV. RESULTS AND DISCUSSION
The system currently in use utilizes product cost information 
which is developed in a process of allocation based more or less on unit 
volume (in milliliter/unit) and biological content of blood products. 
Although unit costs are thus established for each product, they are not 
necessarily closely related to actual costs as they occur or to processing 
fees which are subsequently computed.
The proposed cost system, in contrast, enables the user to identify 
and isolate costs which are uniquely attributable to each product. The 
system's value is not significantly decreased due to the interrelationship 
of blood services products, as one might expect would happen..
According to Dearden*s qualifier:
Sometimes the basic products are so fundamental to the 
business and so interrelated that their separation into 
individual products with different profitability esti­
mates may be meaningless. In such cases, it is usually 
desirable to calculate profitability for those individual 
products that are subject to management discretion with 
respect to discontinuance, expansion, or price change.^
' - ■
To some extent, all blood services are subject to management discre­
tion, particularly in terms of expansi<m of volume and pricing decisions.
It is worthwhile, therefore, to spend the time and concentrated effort to 
evaluate each product. As a result of doing research for this project, 
for example, the unique cost approach uncovered the details of a quality 
control requirement which caused us to decide to make cryoprecipitate in 
one location rather than two.
^Ibid., p. 138.
10
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Unique costs are much easier to develop for specialized services 
and tests than for routine blood services. Data were gathered on costs 
of materials, training, and time required for a six-month period, to 
identify these special costs which were not readily discernible using the 
current system. A decision was needed on whether to charge separately 
for each of these special tests and services, or to add their total cost 
to the fees for the more tangible products, i.e., whole blood and red 
cells. All hospital blood bank directors in the region were surveyed, 
asking which pricing approach they would prefer. A slight majority noted 
a preference for the higher processing fee for blood products, to include 
overall average costs of specialized tests and services.
It should be noted that the concept of service for a regional 
blood service includes the philosophy and practice of supplying all blood- 
related needs to the hospitals within the. region. Whether or not delivery 
of a certain service or product generates revenue equal to its cost, or 
indeed, any revenue at all, is secondary in importance to the fact that 
needs are consistently met. In other words, it is the responsibility of 
the supplier to provide all blood services, regardless of costs of indivi­
dual items or incidents, within the limits imposed by such uncontrollable 
elements as the weather. Secondarily, it is the responsibility of the 
supplier to provide for the continuity of the operation, by planning for 
revenues to equal costs, which are kept as low as possible without com­
promising quality.
In short, the system of unique costing provided additional, use­
ful information about the nature and size of costs in a regional blood 
services center. Unique costs were accurately identified for most products 
and services. In this study alone, important information that actually 
affected operating practices m d  pricing policy.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
V. SUMMABY AND CONCLUSI(»iS
A new cost accounting system for identifying unique costs and 
analyzing profitability of products, product groups and product lines, 
as proposed by John Dearden, was tested, using data on regional blood 
services.
The unique costing system was found to be time consuming, but no 
more so than other systems. However, for the same amount of effort, one 
derives more useful management information than in other systems.
As in any costing system, good use of the system requires a thorough 
understanding of the numerous functions and interrelationships of an organ­
ization. Unless accountants or others who use the system are willing and 
able to absorb unwritten knowledge gleaned from observation of people and 
procedures in the organization studied, the system would not provide accurate 
results. It is probable, therefore, that managers could benefit from utili-̂  
zation of the unique costs approach to profitability analysis, but would 
need to be able to explain it very well in order to enlighten regulators, 
consumers and others who are familiar with more traditional systems.
The unique costing system offers service organizations such as the . 
American Red Cross a managerial tool to generate cost information which 
is significantly more relevant than that provided by traditional approaches. 
Much time, effort and money is spent on budgets, audits, pricing, training, 
conferences, communication and so forth. It is appropriate that the best 
available methods be employed.
12
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Improved accounting procedures utilizing the unique costing 
approach make possible better pricing decisions as well as better ways of 
describing investments in himan assets, research and new technology, which 
provide modem blood services to the patient at the right cost. In other 
words, the unique costing system implies that a new accounting and pricing 
approach would be more useful to service organizatitms, including the 
Merican Red Cross.
Accounting systems for nonbusiness organizations are beginning to 
receive more attention in the literature, but there is still a dearth of 
material on the subject. Since the nonprofit sector, which includes govern­
ments, it apparently growing daily, and because people are Increasingly 
concerned about personal expenditures and public accountability, it seems 
appropriate that more studies be made in the search for better methods of 
determining and describing costs of products, including services.
It is recommended that any person responsible for financial manage-
.
ment of a service organization try this new method next time he or she must 
help evaluate the cost/benefits of a service, prepare or control- a budget, 
explain periodic financial respots, or respond to the need for research in 
this area.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
APPENDIX A
INSTRUCTIONS FOR USE OF THE UNIQUE COSTS WORKSHEET
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INSTRUCTIONS FOR USE OF THE UNIQUE COSTS WORKSHEET
The Unique Costs Worksheet Is designed as an aid In. the Identifi­
cation of uniquely attributable costs of products, product groups, and 
product lines In six cost centers of a regional blood services program. 
The unique cost analysis Is hierarchical; It starts with the broadest 
definition of a product and moves downward to.the narrowest, I.e., a 
unique product or service that cannot be subdivided*
Before attempting to use the form, decide which are the major 
product lines. (e.g., (1) Whole Blood and Components, and (2) Special­
ized Services and Tests). Then define the product groups within each 
produce line. Then list the products which belong In each group. For 
example, a product group called "Red Cell Products," might Include as 
products. Whole Blood, Red Cells, Frozen ^ d  Cells, and Deglycerollzed 
Red Cells.
Prepare a worksheet for each product. Write answers to the 
questions. In the spaces provided, giving names and amounts of unique 
costs, wherever possible. The Information In the "product line," and 
"product group" spaces need not be repeated until the worksheet for the 
next line and group Is started. However, unique cost data should be 
recorded In each "product" space along the bottom of the page.
15
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
APPENDIX B 
UNIQUE COSTS WORKSHEETS COMPLETED
I  b
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UNIQUE COSTS WORKSHEET
American Red Cross Blood Services, Montana Region
Prodùct Lines: (1) Whole Blood and Components; (2) Specialized Services and Tests
Product Groups: (lA) Cell Products; (IB) Plasma Products
(2A) Specialized Tests, Patients; (2B) Specialized Tests, Donors
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Period: July 1, 1980 through June 30, 1981
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Product: Whole Blood 9.000 <^11 Product. Llue: “ ■*
COST CENTERS TOTALS
General
Operations
Donor
Resources Distribution
Reference,
Consultation Collection Preparation
Which costs would not 
have been incurred had 
this product line not 
been produced?
$170,526 $49,626 $96,444 “0“ $271,252 $276,179 $864,027
Which costs would not 
have been incurred had 
this product group not 
been produced?
$ 95,524 $25,162 $52,796 -0- $151,581 $153,250 $478,313
Which costs could have 
been avoided if this 
product had not been 
produced, assuming the 
other products in the 
group had been produced?
—0^ -0- $ 9,000
Shipping 
materials 
and charges
-0- $ 25,326
Collection
Bags
? 34,326
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UNIQUE COSTS WORKSHEET
American Red Cross Blood Services, Montana Region
Product Lines: (1) Whole Blood and Components; (2) Specialized Services and Tests
Product Groups: (lA) Cell Products ; (IB) Plasma Products
(2A) Specialised Tests, Patients; (2B) Specialized Tests, Donors
Period : July 1, 1980 through June 30, 1981
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Product: Red Bipod Cells (Human)
Number
Of Units; 9.575 Group: Cell Products Line:
Whole Blood 
Components
and
COST CENTERS TOTALS
General
Operations
Donor , 
Resources Distribution
Reference, 
Consultation Collection Preparation
Which costs would not 
have been Incurred had 
this product line not 
been produced?
S A M ! A S  W H O L E  B L 0 0 )
Which costs would not 
have been incurred had 
this product group not 
been produced?
S A M E A S  W H 0 j, E B L 0 0 D
Which costs could have 
been avoided If this 
product had not been 
produced, assuming the 
other products In the 
group had been produced?
-0- —0"— $ 9,575
Shipping 
Materials 
and Charges
•—Qw —0— $ 34,300
Collection
Bags
$43,875
00
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UNIQUE COSTS WORKSHEET
American Red Cross Blood Services, Montana Région
Product Lines: (1) Whole Blood and Compwents ; (2) Specialized Services and Tests
Product Groups: (lA) Cell Products; (IB) Plasma Products
(2A) Specialized Tests, Patients; (2B) Specialized Tests, Donors
Period: July 1, 1980 through June 30, 1981
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Product: o M t L :  300 ="11 Product. Line: “ <>
COST CENTERS TOTALS
GeneralOperations
Donor
Resources Distrlbution
Reference,
Consultation Collection Preparation
Which costs would not 
have been Incurred had 
this product line not 
been produced?
S A M E A S  W H 0 L E B L O O D
Which costs would not 
have been incurred had 
this product group not 
been produced?
S A M E \  S W H O  L Î B L O O D
Which costs could have 
been avoided if this 
product had not been
$2,800
Special­
ized, majoi 
equipment
-0- $3,008
Dry Ice; 
Shipping 
materials 
and charges
—Q— -0- $4,672
Supplies,
Time
Training
$10,480
produced, assuming the 
other products in the 
group had been produced?
NO
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UNIQUE COSTS WORKSHEET
American Red Cross Blood Services, Montana Region
Product Lines: (1) Whole Blood and Components ; (2) Specialized Services and Tests
Product Groups: (lA) Cell Products; (IB) Plasma Products
(2A> Specialized Tests, Patients; (2B) Specialized Tests, Donors
8■D
Period: July 1, 1980 through June 30, 1981
CD
3.3"
CD
CD■D
OQ.
C
aO
3■D
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CDQ.
■D
CD
(/)(/)
Product : g ^ r S e i î J è l r i n -  , 125 Group: Cell Products Line: lifhole Blood Components and
COST CENTERS TOTALS
GeneralOperations DonorResources Distribution
Reference,
Consultation Collection Preparation
Which costs would not 
have been incurred had 
this product line not 
been produced?
S A M E i S W H O L E B L O O D
Which costs would not 
have been incurred had 
this product group not 
been produced?
S A M E  A S W H O L E B L O O D
Which costs could have 
been avoided if this 
product had not been 
produced, assuming the 
other products in the 
group had been produced?
$ 4,100
Speclalizec 
Major / 
Equipment
-0- $125 .
Shipping 
Materials 
and Charges
-0- -0- $7,501
Supplies,
Time,
Training
$11,726
N>
O
CD
■ D
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gQ.
■DCD
C /)
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O
UNIQUE COSTS WORKSHEET
American Red Cross Blood Services, Montana Region
Product Lines: (1) Whole Blood and Components; (2) Specialized Services and Tests
Product Groups: (lA) Cell Products; (IB) Plasma Products
(2A) Specialized Tests, Patients; (2B) Specialized Tests, Donors
8
T3
Period: July 1, 1980 through June 30, 1981
3"
i3
. Platelet Concentrate Number Product. ( H u ^ f  Of Unit.! 4.600 Group: Plasma Products Line: Whole Blood Components and
CD
"n
c
COST CENTERS TOTALS
3"CD General Donor Reference,
Operations Resources Distribution Consultation Collection Preparation
"O
o
Q.
C Which costs would not
o have been Incurred had
3
■D this product line not S A M E A S  W H 0 L E B L O O D
O
3"
CT
been produced?
1—HCD
Q.
$ Which costs would not $75,002 $24,464 $43,648 -0- $119,671 $122,929 $385,714
3" have been incurred had
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Product Lines: 
Product Groups:
UNIQUE COSTS WORKSHEET
American Red Cross Blood Services, Montana Region
(1) Whole Blood and Components; (2) Specialized Services and Tests 
(lA) Cell Products; (IB) Plasma Products
(2A) Specialized Tests, Patients; (2B) Specialized Tests, Donors
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Period : July 1, 1980 through June 30, 1981
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Product: 4.600 Line:
COST CENTERS TOTALS
GeneralOperations
Donor
Resources Distribution
Reference,
Consultation Collection Preparation
Which costs would not 
have been incurred had 
this product line not 
been produced?
S A M E A S  W H 0 L E B L O O D
Which costs would not 
have been incurred had 
this product group not 
been produced?
■ S A M E \ S P L A T Ï L E T C O N C E N T R A T E
Which costs could have 
been avoided if this 
product had not been
$3,480
Specialized
Major
Equipment
—0" $6,785
Holders,
Dry Ice, 
Shipping 
Materials
and Charges
—0— —0— $16,468.
Collection
Bags,
Time
$26,733
produced, assuming the 
other products in the 
group had been produced?
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UNIQUE COSTS WORKSHEET
American Red Cross Blood Services, Montana Region
Product Lines: (1) Whole Blood and Components; (2) Specialized Services and Tests
Product Groups: (lA) Cell Products; (IB) Plasma Products
(2A) Specialized Tests, Patients; (2B) Specialized Tests, Donors
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Period : July 1, 1980 through June 30, 1981
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Product : Cryoprecipitate NumberOf Units: 400 Group: Plasma Products Line: Whole Blood Components and
COST CENTERS TOTALS
General
Operations
Donor
Resources Distribution
Reference,
Consultation Collection Preparation
Which costs would not 
have been incurred had 
this product line not 
been produced?
S A M E A S  W H 0 L E B L O O D
Which costs would not 
have been incurred had 
this product group not 
been produced? S A M  E A S  P L A T E L E T C O N  C E N T R A T E
Which costs could have 
been avoided if this 
product had not been 
produced, assuming the 
other products in the 
group had been produced?
-0- —0— $2,600
Holders, 
Dry Ice, 
Shipping 
Materials 
and Charges
-0- —O™ $2,152
Collection
Bag,
Time
$4.752
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UNIQUE COSTS WORKSHEET
American Red Cross Blood Services, Montana Région
Product Lines: (1) Whole Blood and Components; (2) Specialized Services and Tests
Product Groups: (lA) Cell Products; (IB) Plasma Products
(2A) Specialized Tests, Patients; (2B) Specialized Tests, Donors
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Period: July 1, 1980 through June 30, 1981
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Product: 5,400 Group: Plasma Products Line : Whole Blood Components and
COST CENTERS TOTALS
General
Operations
Donor
Resources Distribution
Reference,
Consultation Collection Preparation
Which costs would not 
have been incurred had 
this product line not 
been produced?
S A M E A S  W H 0 L E B L O O D
Which costs would not 
have been Incurred had 
this product group not 
been produced?
S A M E A S  P L A T  E L E T C O N  C E N T I A T E
Which costs could have 
been avoided if this 
product had not been 
produced, assuming the 
other products in the 
group had been produced?
—0— "O"" $5,324
Shipping 
Materials 
and Charges
—0"* -0- $17,626
Collection
Bag,
Time
$22,950
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UNIQUE COSTS WOBKSHEET
American Red Cross Blood Services, Montana Region
Product Lines: (1) Whole Blood and Components; (2) Specialized Services and Tests
Product Groups: (lA) Cell Products; (IB) Plasma Products
(2A) Specialized Tests, Patients; (2B) Specialized Tests, Donors
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Product:
Number
Of Units : 162 Group-: Plasma Products Line:
Whole Blood 
Components
and
COST CENTERS TOTALS
' . GeneralOperations
Donor
Resources Distribution
Reference,
Consultation Collection Preparation
Which costs would not 
have been incurred had 
this product line not 
been produced?
S A M E A S  W H O ! E B L O O D
Which costs would not 
have been incurred had 
this product group not 
been produced?
S A M  E A S  P L i T E L E T C 0 N C E N t I A T E
Which costs could have 
been avoided if this 
product had not been 
produced, assuming the 
other products in the 
group had been produced?
-0- -0- $ 683
Shipping 
Materials 
and Charges
-0- -0— $ 928
Pooling
Bag,
Time
$1,611
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Product Lines: 
Product Groups:
UNIQUE COSTS WORKSHEET
American Red Cross Blood Services, Montana Region
(1) Whole Blood and Components; (2) Specialized Services and Tests 
(lA) Cell Products; (IB) Plasma Products
(2A) Specialized Tests, Patients; (2B) Specialized Tests, Donors
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Period : July 1, 1980 through June 30, 1981
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Product: Ph^nofyped NumberOf Units: 300 Group: Special Tests, Donors Line:
Specialized Services and Tests
COST CENTERS TOTALS
GeneralOperations DonorResources Distribution
Reference,
Consultation Collection Preparation
Which costs would not 
have been incurred had 
this product line not . 
been produced?
$24,207 —0-̂ ^0— $76,045 $17,040 -0^ $117.292
Which costs would not 
have been incurred had 
this product group not 
been produced?
$ 1,399 —*0" $ 6,226 -0- $ 7,625
Which costs could have 
been avoided if this 
product had not been 
produced, assuming the 
other products in the 
group had been produced?
-0- -0- -0- $ 4,101
Supplies,
Time
“0— ^0- ? 4,101
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UNIQUE COSTS WORKSHEET
American Red Cross Blood Services, Montana Region
Product Lilies: (1) Whole Blood and Components; (2) Specialized Services and Tests
Product Groups : (lA) Cell Products; (IB) Plasma Products
(2A) Specialized Tests, Patients; (2B) Specialized Tests, Donors
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Product. Fheresls Of Units: 52
Specialized Services and Tests
(X)ST CENTERS TOTALS
General
Operations
Donor
Resources Distribution
Reference,
Consultation Collection Preparation
Which costs would not 
have been incurred had 
this product line not 
been produced?
S A M E A S D 0 N 0 R S P H E N 0 T Y P i D
Which costs would not 
have been incurred had 
this product group not 
been produced?
$22,808 -0- $69,819 $17,040 —0— $109,667
Which costs could have 
been avoided If this 
product had not been 
produced, assuming the 
other products In. the 
group had been produced?
$ 4,000
Speclpllax
Major
Equipment
-0- -0- —0— $16,147
Training,
Supplies,
Time.Quality
Control
-0- $ 20,147
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UNIQUE COSTS WORKSHEET
American Red Cross Blood Services, Montana Region
Product Lines: (1) Whole Blood and Components; (2) Specialized Services and Tests
Product Groups: (lA) Cell Products; (IB) Plasma Products
(2A) Specialized Tests, Patients; (2B) Specialized Tests, Donors
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Product: Hepatitis Tests NumberOf Units : 500 Group: Un.=
Speclallzed Services and Tests.
COST CENTERS TOTALS
General
Operations
Donor
Resburces Distribution
Reference,
Consultation Collection Preparation
Which costs would hot 
have been Incurred had 
this product line not 
been produced?
S A M E A S D 0 N 0 R S P H E N O  T Y P I D
Which costs would not 
have been Incurred had 
this product group not 
been produced?
S A M E I S P L  A r E L E T C 
3 Y P H E R
0 N C E N T R 
B S I S
I T E
Which costs could have 
been avoided If this 
product had not been 
produced, assuming the 
other products In the 
group had been produced?
— 0— -0- -0- $ 2,055
Supplies, 
Time
-0- -0- $2,055
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UNIQUE COSTS WORKSHEET
American Red Cross Blood Services, Montana Region
Product Lines: (I) Whole Blood and Components; (2) Specialized Services and Tests
Product Groups: (lA) Cell Products; (IB) Plasma Products
(2A) Specialized Tests, Patients; (2B) Specialized Tests, Donors
Period:
8■D
July 1, 1980 through June 30, 1981
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_ .  ̂ Autologous Product : Transfusions NumberOf Units: 30
Specialized 
Services, Patients Line:
Speclallzed Services and Tests
' , COST CENTERS TOTALS
General
Operations
Donor
Resources Distribution
Reference,
Consultation Collection Preparation
Which costs would not 
have been Incurred had 
this product line not 
been produced?
S A M E A S  D 0 N 0 R S P H E N 0 T Y P E D
Which costs would not 
have been Incurred had 
this product group not 
been produced?
S A M E  A S P L A T E L E 
B Y  P H E E
T C O N G E  
E S I S
S T R A T E
Which costs could have 
been avoided If this 
product had not been 
produced, assuming the 
other products In the 
group had been produced?
«—0"" -0- -0- $990
Time only
-0- -0- $990
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UNIQUE COSTS WORKSHEET
American Red Cross Blood Services, Montana R.egion
Product Lines: (1) Whole Blood and Components; (2) Specialized Services and Tests
Product Groups: (lA) Cell Products; (IB) Plasma Products
(2A) Specialized tests. Patients; (2B) Specialized Tests, Donors
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Period : July 1, 1980 thrpugh June 30, 1981
Product NumberOf Units: 30 croup: tin.:
Specialized 
Services and Tests
COST CENTERS TOTALS
General
Operations DonorResources Distribution
Reference,
Consultation Collection Preparation
Which costs would not 
have been incurred had 
this product line not 
been produced?
S A M E A S D O  N 0 R S P H E N 0 T Y > E D
Which costs would not 
have been incurred had 
this product group not 
been produced?
S A M E A S P L A T E L E ' 
B Y  PI
C O  N C E N 
E R E S I S
[ R A T E
Which costs could have 
been avoided if this 
product had not been 
produced, assuming the 
other products in the 
group had been produced?
-0- -0- $1,355
Bag
Pheresis
SuppliesTime
—0— -0- $1,355
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UNIQUE COSTS WORKSHEET
American Red Cross Blood Services, Montana Region
Product Lines: (1) Whole Blood and Components; (2) Specialized Services and Tests
Product Groups: (lA) Cell Products; (IB) Plasma Products
(2A) Specialized Tests, Patients; (2B) Specialized Tests, Donors
Period: July 1, 1980 through June 30, 1981
n j Special Red Cell Product : Typings for Patients
Number
Of Units: 3,000 Group: Line:
Speciallzed Services and Tests
COST CENTERS TOTALS
General
Operations
Donor
Resources Distribution
Reference,
C&nsultation Collection Preparation
Which costs would not 
have been Incurred had 
this product line not 
been produced?
S A M E  A S D O N O R S P H E N 0 T Y » E D
Which costs would not 
have been incurred had 
this product group not 
been produced?
S A M E A S P L A T E L E 1 
B Y  P Ï
C O N  C E N  
E R E S I S
C R A T E
Which costs could have 
been avoided if this 
product had not been 
produced, assuming the 
other products in the 
group had been produced?
—0- -0- “0“ $33,390
Supplies, 
Time
-0- -0- $33,390
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UNIQUE COSTS WORKSHEET
American Red Cross Blood Services, Montana Region
Product Lines: (1) Whole Blood and Components; (2) Specialized Services and Tests
Product Groups: (lA) Cell Products; (IB) Plasma Products
(2A) Specialized Tests, Patients; (2B) Specialized Tests, Donors
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Period : July 1, 1980 through June 30, 1981
Product: Compatibility Screen
Number 
Of Units: 300 Group: Lino:
COST CENTERS TOTALS
General
Operations
Donor
Resources )istrlbution
Reference,
Consultation Collection Preparatlon
Which costs would not 
have been incurred had 
this product line not 
been produced?
S A M E A S D O N O R S P H E N 0 T Y » E D
Which costs would not 
have been incurred had 
this product Rroup not 
been produced?
S A M E A S P L A T E L E 1 
B Y  P Ï
C 0 N C E N 
E R E  S I S
C R A T E
Which costs could have 
been avoided if this 
product had not been 
produced, assuming the 
other products in the 
group had been produced?
-0- "-Q— -0- $ 1,596
Supplies, 
Time
-0- —Q— $1,596
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UNIQUE COSTS WORKSHEET
American Red Cross Blood Services, Montana Region
Product Lines: (1) Whole Blood and Components ; (2) Specialized Services and Tests
Product Groups: (lA) Cell Products; (IB) Plasma Products
(2A) Specialized Tests, Patients; (2B) Specialized Tests, Donors
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Product- Patient Red Cell Number
Problem Cases Of Units: 120 Group: Li..:
Specialized 
Services and Tests
COST CENTERS TOTALS
GeneralOperations DonorResources Distribution
Reference, 
Consultation Collection Preparation
Which costs would not 
have been incurred had 
this product line not 
been produced?
S A M E  A S D O N O R S P H E N 0 T Y ? E D
Which costs would not 
have been incurred had 
this product group not 
been produced?
S A M E A S P L A T E L E 1 
B Î P f
C 0 N C E N 
E R E S I S
[ R A T E
Which costs could have 
been avoided if this 
product had not been 
produced, assuming the 
other products in the 
group had been produced?
-0- , —0— —0"" $1,872
Supplies,
Time
-0- —0— $1,872
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ALLOCATION OF JOINT COSTS
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ALLOCATION OF JOINT COSTS
The problem of Imperfect cost allocation methods of accounting 
for non-unique costs called overhead, joint, indirect and so forth, was 
recognized. In a non-profit, self-sufficient organization all costs 
must be covered, one way or another. In a regional blood service, most 
revenues derive from processing fees charged to participating hospitals.
It is therefore Important that prices be set as fairly and as low as 
possible, but accurately enough to ensure that total revenue will equal 
total costs.
Although the unique costing approach is very helpful, and although 
allocation of joint costs is not very helpful in pricing decisions, the 
need for thoughtful, simultaneous use of both approaches is inescapable. 
Exquisite accuracy is equally impossible.
Most cost allocation systems seem to employ mirror or circular 
thinking, "This product will fetch this many dollars, so we will assign 
this much cost to it." The ability to bear the cost, itself, determines 
the allocated cost. This practice is accepted, is not really logical, 
produces bizarre results, but will continue to occur until a better system 
is developed.
In this study, a cause-and-effect type of relationship was used 
as a basis for cost allocation. The question was asked, "Does the activity 
of this department (or Cost Center) contribute in an essential way, to the 
production and delivery of this product?" If the answer was "Yes," depart­
mental costs were allocated evenly to each unit of product or service which
35
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depended upon the specific activity of that department« By allocating in 
this fashion, recognition was given to the fact that every unit handled 
cost some amount of time, space, energy, paperwork, and other resources 
that could not be uniquely or quantifiably attributed to the unit. No 
attempt was made to account for differing amounts of activity associated 
with different products (much of this was already done in the unique 
costing process). No recognition of traditional values such as finished 
goods value, or value at split-off point was given, in order to focus on 
finding a method to measure costs independently from revenues.
Costs based on this cause-and-effect approach to cost allocation 
used together with the unique costing system were quite different from 
costs based more or less on the currently used "abllity-to-bear" approach. 
Accurate identification of costs is important for pricing decisions, but 
even in cases where costs do not strongly influence prices, the extent to 
which a product is subsidizing or being subsidized is clarified.
Details of the allocation of joint costs in this study follow;
1. General Operations 
Unique Costs ■ $15,180
Joint Costs - Total Departmental Costs r. Total Unique
Departmental Costs
Joint Costs - ($194,733 - $15,180) « $179,553
Allocate to all 38,494 products and tests:
$179,553 ♦ 38,494 « $4.6644412 per unit.
2. Donor Resources 
Unique Costs - $4,600
Joint Costs * ($49^626 - $4,600) - $45,026
Allocate to all Cell and Plasma products, except pooled 
Plasma:
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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19,000 + 4,600 + 4,600 + 400 + 5,400 » 34,000 units
$45,026 * 34,000 - $1.3242941 per unit
3. Distribution
Unique Costs ■ $40,550
Joint Costs - ($96,444 - $40,550) - $55,894
Allocate to all Cell and Plasma products - 34,162
$55,894 i  34,162 - $1.6361454 per unit.
4. Reference and Consultation 
Unique Costs ■ $45,359
Joint Costs - ($76,045 - 45,359) » $30,686
Allocate to 4,332 Special Services and Tests;
$30,686 T 4,332 = $7.0835641 per unit.
5. Collection
Unique Costs * $16,147
Joint Costs - C$288,292 - $16,147) = $272,145
Allocate to all Cell and Plasma products except Pooled Plasma 
34,000 units, plus 52 Pheresis Platelets, 30 Autologous trans­
fusions, 30 therapeutic phlebotomies 34,112 total units
$272,145 i 34,112 - $7.9779842 per unit,
6. Preparation
Unique Costs « $129,731
Joint Costs - ($276,179 - $129,731) = $146,448
Allocate to all Cell and Plasma products = 34,162 units
$146,448 t 34,162 - $4.2868684 per unit.
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SUMMARY OF JOINT AND UNIQUE COSTS
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CD
■ DO
Q .C
g
Q .
■D
CD
C/)W
o"3O
8■D
CD
3.3"
CD
CD■DO
Q .C
aO
3■DO
CD
Q .
■D
CD
C/)
C/)
WvD
(NOTE:
SUMMARY OF JOINT AND UNIQUE COSTS
American Red Cross Blood Services 
Montana Region
For the Period: July 1, 1980 through June 30, 1981
For each product allocated joint costs are listed on the first 
line, and unique costs are listed on the second line.)
Product
Departments (Cost Centers)
Total
Number 
of Units
General
Operations
Donor
Resources Distrlbution
Reference,
Consultation Collection Preparation
Whole Blood 9,000 $ 41,980 $11,919 $14,725 -0- $ 71,802 $ 38,582 $179,008
-0- -0- 9,000 -0- 25,326 34,326
Red Cells 9,575 44,662 12,680 15,666 -0- 76,389 41,047 190,444—0“ -0- 9,575 —0— 34,300 43,875
Frozen Cells 300 1,399 397 491 -0— 2,393 1,286 5,966
2,800 —0— 3,008 -0- -0- 4,672 10,480
Deglycemlzed
Cells 125 583 166 206 —O'" 997 536 2,488
4,100 —0— 125 —Q— —0— ' 7,501 11,726
Platelets 4,600 21,456 6,092 7,526 36,699 19,720 91,493
800 4,600 3,450 —O" -0- 20,758 29,608
Frozen Plasma 4,600 21,456 6,092 7,526 —O"" 36,699 19,720 91,493
3,480 -0- 6,785 -0— -0- 16,468 26,733
Cryoprecipitate 400 1,866 530 654 —O'* 3,192 1,715 7,957
-0- -0- 2,600 —O'* -0- 2,152 4,752
Liquid Plasma 5,400 25,188 7,150 8,835 —0— 43,081 23,148 107,402
,
-0- -0- 5,324 -O'* -0— 17,626 22,950
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Product
Departments (Cost Centers)
Total
Number 
of Units
General
Operations
Donor
Resources Dlstribution
Reference,
Consultation Collection Preparation
Pooled Plasma 162 $ 756 $ 256 *0— ^0" $ 694 $ 1,715-Or -0- 683 -0- -0- 928 1,611
Donors
Phenotyped 300 1,399 -0- -0- 2,125 -0- T«0— 3,524
-0- -0- ^0" 4,101 —0"" -0- 4,101
Pheresis
Platelets 52 243 -0- 368 415 —Q— 1,026
4,000 *0*“ ' -0- -0- 16,147 -0- 20,147
Hepatitis Tests 500 2,332 -0- —0"" 3,542 -0- -0- 5,874
-0- -0- -0- 2,055 -0- “0" 2,055
Autologous
Transfusions 30 140 -0- -0- 213 239 —0- 592-0- -0- —0— 990 -0- 990
Therapeutic
Phlebotomies 30 140 —O'* -0- 213 239 -0- 592
-0- , -0- -0- 1,355 —0— -0— 1,355
Red Cell Tests
on Patients 3,000 13,993 ' -0— —0- 21,250 -0- —0— 35,243—Q— ■“0“ -0- 33,390 -0- —0— 33,390
Compatibility
Screens 300 1,399 —0— -0- 2,125 -0- -0- 3,524
-0- —Q— -0- 1,596 —0“* -0" 1,596
Patient Red Cell
Problem Cases 120 561 —O'* —0- 850 —0— —Q— 1,411
• —0"* -0- -0- 1,872 -0- -0- 1,872
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SUMMARY W  JOINT AND UNIQUE COSTS (Continued)
Products
TOTALS 
Joint Costs 
Unique Costs 
Combined Costs
Departments (Cost Centers)
Number 
of Units
38,494
General
Operations
$179,553 
$ 15,180 
$194,733
Donor 
Resources
$45,026 
$ 4,600 
$49,626
Distribution
$ 55,894 
$ 40,550 
$ 96,444
Reference,
Consultation
$ 30,686 
$ 45,359 
$ 76,045
Collection
$272,145 
$ 16,147 
$288,292
Preparation Total
$146,448
$129,731
$276,179
$729,752
$251,567
$981,319
APPENDIX E
SUMMARY OF UNIQUE COSTS, REVENUES AND PROFITS
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SUMMARY OF UNIQUE COSTS, REVENUES AND PROFITS
American Red Cross Blood Services, Montana Region
For the Period: July 1, 1980 through June 30, 1981
PRODUCTS, GROUPS, LINES REVENUE
UNIQUE
COSTS
PROFITS 
OR (LOSS)
Whole Blood 
Red Cells 
Frozen Cells 
Deglycerlnized Cells
For the Cell Products Group
Platelet Concentrate 
Frozen Plasma 
Cryoprecipitate 
Liquid Plasma, Single 
Pooled Plasma
For the Plasma Products Group
For the Whole Blood and 
Component Product Line
Donors Phenotyped 
Pheresis Platelets 
RIA Tests
Autologous Transfusions 
Therapeutic Phlebotomies 
Red Cell Tests on Patients 
Conqpatibility Screens 
Patient Red Cell Problems
For the Specialized Services 
and Tests Product Line
TOTALS, For Individual Products
TOTALS, For Both Product Lines
TOTALS, For the Center as a Whole, 
Including "Other” Revenues and ' 
Expenses
390,894
418,213
17,700
10,810
837,617
50,600
43,400
2,800
16,200
4,440
$ 117,440
34,326
43,875
10,480
11,726
478,313*
29,608
26,733
4,752
22,950
1,611
$ 385,714*
$356,568
374,338
7,220
(916)
$359,304
$ 20,992 
16,667 
(1,952) 
(6,750) 
2,829
($268,274)
955,057 $ 864,027 $ 91,030
-0- $ 4,101 $ (4,101)
10,500 20,147 (9,647)
1,000 2,055 (1,055)
990 C990)
^0— 1,355 (1,355)
"-O™ 33,390 (33,390)
-0- 1,596 (1,596)
-0- 1,872 (1,872)
11,500 $ 117,292 ($105,792)
966,557 $ 251,567 $714,990
966,557 $ 981,319* ($ 14,762)
$1,000,319 $1,000,319 »-0—
*Includes costs which are joint with respect to individual products.
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PRICING APPLICATIONS
If prices are set so revenues for each product are equal to costs 
which have been determined by a unique costing system used together with 
a cause-and-effect-allocation-of-Joint-costs system, then prices would 
resemble the following list (assuming the expected number of units are 
utilized, outdated, or spent for quality control). Prices set by current 
methods are listed for comparison.
Product Current Price "New-Method"
Whole Blood $ 49.75 $ 26.34
Red Cells 49.75 30.36
Frozen Cells 59.00 54,82
Deglycerinized Cells 94.00 123.60
Platelets 22.00 52.65
Frozen Plasma for Transfusion 22.00 25.70
Frozen Plasma for Fractionation 5.00 25.70
Cryoprecipitate 8.00 36.31
Liquid Plasma 3.00 24.14
Pooled Plasma 3.00 20.53
Donors Phenotyped —0— 25.42
Pheresis Platelets 300.00 604.94
Hepatitis Tests 10.00 15.86
Autologous Transfusions -0- 52.73
Therapeutic Phlebotomies —0— 64.90
Red Cell Tests on Patients —0— 22.88
Compatibility Screens -0- 17.07
Patient Red Cell Problems -0- 27.36
It can readily be seen that the new costing system implies utili­
zation of a pricing system so radically different, it would not be accepted 
in the near future. However, the new approach surely does point up the 
extent to which some products subsidize others.
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Also, the unique costing approach Identifies specific Incremental 
costs which "should" be recovered, even though the particular product may 
not have the "ability to bear" Its share of allocated costs. For example, 
single donor liquid plasma which could possibly be considered a by-product, i
"should" fetch $4.25, ($22,950 -r 5,400), per unit, minimum, to recover |
unique costs alone. !
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Comparative Income Statements
CURRENT METHOD 
Income
Whole Blood and Components $928,900
Plasma for Further Manufacturing 37,640
Specialized Services and Tests so­
other Income (Interest, etc.) 14,779
Total Income $981,319
Expense
Direct Materials $103,000
Indirect Expenses 849,474
Major Equipment 28.845
Total Expense $981,319
Increase (decrease) in Fund Balance -̂ O-
NEW METHOD 
Income
Whole Blood and Components $864,027
Specialized Services and Tests 117,292
Total IncOTie $981,319
*Expense
Unique Costs $251,567
Joint Costs 729,752
Total Expense $981,319
Increase (̂ decrease) in Fund Balance -0-
*Altematively, expenses could be shown as;
Expense
Whole Blood and Components $864,027
Specialized Services and Tests 117,292
Total Expense $981,319
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